Skip to main content


Fig. 1 | BMC Ophthalmology

Fig. 1

From: Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study

Fig. 1

Mean change in best-corrected visual acuity (BCVA) from baseline after each dexamethasone intravitreal implant (DEX implant). Results are shown for patients with retinal vein occlusion who were treatment-naïve at the time of the first DEX implant treatment. a All treatment-naïve patients. b Treatment-naïve patients diagnosed with branch or central retinal vein occlusion (BRVO, CRVO). Numbers in parentheses indicate number (n) of patients included in analysis (all patients with available data). Error bars, standard deviation. *P ≤ 0.034 vs baseline

Back to article page